Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Clinical Diagnostics — Goodwill, Foreign Currency Translation, Gain (Loss)

Other segment segments

Life Science
-$2.7M—

Similar metrics at other companies

Danaher logo
DHRDiagnostics — Goodwill, Foreign Currency Translation, Gain (Loss)
$56.75M+246%
TEC
TECHDiagnostics And Spatial Biology — Goodwill Foreign Currency Translation Gain Loss
-$1.05M-139%
WAT
WATWaters Advanced Diagnostics — Goodwill Foreign Currency Translation Gain Loss
$7M—
Ecolab logo
ECLGlobal Healthcare And Life Sciences — Goodwill Foreign Currency Translation Gain Loss
-$24.2M-262%
Danaher logo
DHRLife Sciences — Goodwill, Foreign Currency Translation, Gain (Loss)
$135.5M+374%
Universal Health Services logo
UHSAcute Care Services — Goodwill Foreign Currency Translation Gain Loss
$0—

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s clinical diagnostics — goodwill, foreign currency translation, gain (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s clinical diagnostics — goodwill, foreign currency translation, gain (loss)?
Bio-Rad Laboratories, Inc. (BIO.B) reported clinical diagnostics — goodwill, foreign currency translation, gain (loss) of $0 in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s clinical diagnostics — goodwill, foreign currency translation, gain (loss) changed year-over-year?
Bio-Rad Laboratories, Inc.'s clinical diagnostics — goodwill, foreign currency translation, gain (loss) decreased by 100.0% year-over-year, from $4.1M to $0.
What does clinical diagnostics — goodwill, foreign currency translation, gain (loss) mean?
The impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency for the Clinical Diagnostics segment. This reflects non-cash adjustments due to global operations.